A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Clinical trial NCT00225615 · COMPLETED

Trial details

NCT number: NCT00225615
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Phenylketonurias

Start date: 2005-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.